Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 15,456 shares at $110.05 ($1.7M) on 2022-02-01, disclosed to the SEC on 2022-02-02.
Open-market sale of $1.7M KRTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.05 | 7,728 | $850K | 50.0% |
| 2 | $110.05 | 7,728 | $850K | 50.0% |
| Total | $110.05 avg | 15,456 | $1.7M | 100% |
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |